| Шығарылым |
Атауы |
Файл |
| № 3 (2010) |
Chronic kidney disease in women |
|
|
Mukhin N., Moukhin N.
|
| № 1 (2015) |
Chronic kidney disease (CKD) in disadvantaged populations |
|
|
Garcia-Garcia G., Jha V.
|
| Том 12, № 4 (2020) |
Chronic kidney disease in patients with impaired thyroid function |
|
|
Bolotova E., Dudnikova A., Kiyanitskaya I.
|
| № 3 (2014) |
Chronic kidney disease in elderly: diagnostic and management challenges |
|
|
Fomin V., Milovanov Y., Yu Milovanova L., Moisseev S., Moukhin N.
|
| Том 14, № 1 (2022) |
Chronic Kidney Disease: Non-invasive Diagnosis of Chronic Renal Failure by Monochrome Nanoparticle Analysis |
|
|
Choi E.
|
| № 4 (2012) |
Khronicheskaya bolezn' pochek: osnovnye printsipy skrininga, diagnostiki, profilaktiki i podkhody k lecheniyu |
|
|
- -.
|
| № 1 (2010) |
CHRONIC PROGRESSIVE NEPHROPATHIES IN ELDERLY PATIENTS |
|
|
- -.
|
| № 3 (2012) |
KhRONIChESKIY GLOMERULONEFRIT I SERDEChNO-SOSUDISTAYa SISTEMA |
|
|
Murkamilov I., Kaliev R., Fomin V., Kaliev K., Ayypova D., Imanov B.
|
| № 3 (2010) |
Chronic glomerulonephritis: arguments for cyclosporine use |
|
|
Kozlovskaya L.
|
| Том 15, № 1 (2023) |
Chronic dialysis in elderly and senile patients: survival and factors affecting outcome. Single-center experience |
|
|
Kurilovich K., Komissarov K., Krasko O.
|
| Том 17, № 1 (2025) |
Chronic pyelonephritis as a mimics of kidney tuberculosis |
|
|
Kulchavenya E., Kholtobin D., Shevchenko S.
|
| № 1 (2017) |
Chronic kidney disease and atrial fibrillation |
|
|
Dyadik A., Yarovaya N., Suliman Y., Zborowskyy S., Merkurev V., Kugler T.
|
| № 1 (2012) |
Health centers: opportunities and perspectives in early diagnosis of heart failure and kidney involvement in patients with arterial hypertension |
|
|
Arutyunov G., Oganezova L., Sokolova A., Arutiunov G., Oganezova L., Sokolova A.
|
| № 2 (2013) |
Cystatin C and target organ damage in arterial hypertension |
|
|
Rebrov A., Kuklina A.
|
| № 2 (2017) |
Cytokine model of the development of cardiovascular complications in chronic kidney disease |
|
|
Murkamilov I., Fomin V., Aitbaev K., Rayimzhanov Z., Redzhapova N., Yusupov F., Aydarov Z.
|
| Том 14, № 3 (2022) |
Cytokine profile and cardiovascular status in patients with chronic kidney disease after covid-19 |
|
|
Zhmurov D., Zhmurov V., Petrov I., Petelina T., Gapon L., Yaroslavskaya E., Petrova Y., Zhmurova E., Ermakova A., Ermakova P.
|
| № 4 (2018) |
Cytokines and arterial stiffness at the early stage of chronic kidney disease: the relationship and prognostic role |
|
|
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Sabirov I.
|
| № 1 (2009) |
Citoprotective effects of erythropoietin |
|
|
Zakharov Y.
|
| № 4 (2013) |
Frequency and predictors of acute kidney injury in patients after surgical correction of heart valve disease |
|
|
Iskenderov B., Sysina O.
|
| № 2 (2015) |
Percutaneous nephrolithotripsy for staghorn renal calculi of KN-1-3 degrees: pro et contra |
|
|
Podojnicyn A., Dutov V., Urenkov S., Ivanov A., Amosov N.
|
| № 1 (2010) |
SH.I. RATNER AND HIS ROLE IN THE STUDY OF HEMORRHAGIC FEVER WITH RENAL SYNDROME ON RUSSIAN EAST (TO 110-TH ANNIVERSARY OF HIS BIRTH) |
|
|
- -.
|
| № 1 (2019) |
The evolution of anemic syndrome against the background of chronic kidney disease in real clinical practice |
|
|
Korneeva S., Pribylov S., Bezgin A., Trigub A.
|
| Том 16, № 2 (2024) |
Evolution of concepts about kidney functions and their role in the regulation of water and mineral metabolism |
|
|
Koroshchenko G., Subotyalova A., Aizman R., Subotyalov M.
|
| Том 12, № 3 (2020) |
Ezetimibe in chronic kidney disease: an effect on the risk of developing cardiovascular and cerebral complications |
|
|
Murkamilov I., Sabirov L., Fomin V., Murkamilova Z., Yusupov F., Redzhapova N., Rayimzhanov Z.
|
| Том 13, № 2 (2021) |
Economic evaluation of renal replacement therapy strategies in Moscow |
|
|
Antonov A., Bezdenezhnykh T., Trifonova A., Kotenko O., Omelyanovskiy V., Musina N.
|
| № 5 (2013) |
Phosphate-binder therapy: economical aspects |
|
|
Mikhailova N.
|
| № 2 (2011) |
Experimental models of renal tubulointersitial damade in arterial hypertension |
|
|
Arutyunov G., Sokolova A., Oganezova L.
|
| № 2 (2009) |
Experimental models of chronic nephropathies |
|
|
Paltseva E.
|
| Том 14, № 2 (2022) |
Expert judgement «Correction of hyperkalemia in CKD. Modern possibilities and therapeutic relevance» |
|
|
Mikhailova N.
|
| Том 14, № 3 (2022) |
Expert opinion. Low-protein high caloric enteral nutrition «Fresubin Renal» in nephrology |
|
|
Shutov E.
|
| Том 14, № 2 (2022) |
Expert Council «Therapy of mineral and bone disorders in CKD. Sevelamer carbonate: from control of hyperphosphatemia to pleiotropic effects» |
|
|
- -.
|
| № 3 (2018) |
Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage |
|
|
Lysenko M., Frolova N., Ketskalo M., Dyakova E., Sysoeva I., Zhilinskaya T., Kotenko O., Volgina G.
|
| Том 13, № 4 (2021) |
Endothelial dysfunction in patients with chronic kidney disease: prognostic potential of endothelin-1 |
|
|
Gasanov M., Panchenko M., Batyushin M., Bronovitskaya N., Razina A.
|
| № 2 (2018) |
Epigenetic regulation of renal fibrosis in diabetic nephropathy: focus on histone modifications |
|
|
Aitbaev K., Murkamilov I., Murkamilova Z., Fomin V.
|
| Том 14, № 2 (2022) |
Epidemiology of covid-19 in patients on renal replacement therapy in the Russian federation in 2021 (brief report) |
|
|
Shilov E., Shilova M., Rumyantseva E., Yesayan A., Kotenko O.
|
| Том 13, № 1 (2021) |
Epidemiology of COVID-19 in patients receiving renal replacement therapy in the Russian Federation: results of 2020 |
|
|
Shilov E., Kotenko O., Shilova M., Milchakov K., Rumyantseva E., Khalfin R.
|
| № 2 (2013) |
Arterial hypertension epidemiology: associations with renal involvement and salt-sensitivity phenomena |
|
|
Arutyunov G., Oganezova L., Dragunov D., Sokolova A.
|
| Том 11, № 3 (2019) |
Epidemiology of chronic kidney disease among residents of Moscow |
|
|
Dudko M., Kotenko O., Shutov E., Vasina N.
|
| № 1 (2010) |
ESSENTIAL ARTERIAL HYPERTENSION AND CHRONIC RENAL FAILURE IN PATIENTS WITH LONG-TERM FOLLOW-UP IN MULTIDISCIPLINARY OUTPATIENT HEALTH CARE FACILITY |
|
|
Alekseeva L., Popova L., Ryzhenkova I., Alekseeva L., Popova L., Ryzhenkova I.
|
| Том 12, № 2 (2020) |
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy |
|
|
Volgina G., Mikhailova N.
|
| № 3 (2018) |
Effect of dialyzer with vitamin E on treatment of anemia and inflammation level |
|
|
Shutov E., Balkarova O., Kotlyarova G.
|
| Том 14, № 4 (2022) |
The effectiveness of hydroxychloroquine and its effect on cell-mediated and humoral immunity in patients with immunoglobulin A nephropathy: results of a prospective controlled study |
|
|
Komissarov K., Nizheharodava D., Minchenko E., Ivanchik G., Pilotovich V., Zafranskaya M.
|
| Том 14, № 2 (2022) |
Effectiveness and safety of SGLT-2 inhibitors for renal allograft recipients with post-transplant diabetes mellitus: an open single-center prospective study |
|
|
Novikova M., Allazova S., Molina L., Koteshkova O., Antsiferov M., Kotenko O., Shilov E.
|
| Том 12, № 3 (2020) |
The efficacy and safety of the sucroferric oxyhydroxide (Velphoro®) in hemodialysis patients: results of a prospective randomized controlled trial |
|
|
Shutov E., Kotlyarova G., Lysenko K., Ryabinskaya G., Lashutin S.
|
| № 2 (2019) |
Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial |
|
|
Shilo V., Alihanova L., Babich V., Vishnevskii K., Zhdanova I., Zuev A., Kalachik O., Kotova L., Legotin A., Sabodash A., Suchkov V., Timokhovskaia G., Toropilov D., Tutin A., Priluckij S., Fedotova L., Khadikova N., Morozova M., Bolsun D., Dokukina E., Linkova Y., Ivanov R.
|
| Том 13, № 2 (2021) |
Efficacy and safety of etelcalcetide compared with cinacalcet in patients received hemodialysis with secondary hyperparathyroidism. Results from a prospective randomized trial |
|
|
Shutov E., Kotlyarova G., Lysenko K., Ryabinskaya G., Lashutin S., Markelova I., Rubleva S.
|
| Том 15, № 2 (2023) |
Effectiveness of treatment with glucocorticosteroids in immunoglobulin A nephropathy with active proliferative histopatological changes |
|
|
Komissarov K., Krasko O., Minchenko E., Pilotovich V.
|
| № 5 (2011) |
SUCCESFUL RITUXIMAB THERAPY OF MEMBRANOUS NEPHROPATHY, RESISTANT TO STANDARD IMMUNOSUPRESSIVE TREATMENT |
|
|
Pulin A., Gornostaeva E., Roshchupkina S., Kozlovskaya L., Fomin V., Mukhin N.
|
| № 3 (2013) |
Modification of diet efficacy in renal transplant recipients |
|
|
Zuglova E.
|
| Том 17, № 3 (2025) |
Efficiency of dyslipidemia therapy using Inclisiran in a series of clinical observations of kidney transplant patients |
|
|
Kordonova O., Gubarev K., Voskanyan S., Praskurnichy E., Svetlakova D., Rudakov V., Frolova N., Vinogradov V., Usatyuk S.
|
| № 4 (2009) |
IS THE ALCOHOL CONSUMPTION THE RISK FACTOR FOR CHRONIC KIDNEY DISEASE? |
|
|
- -.
|
| Нәтижелер 951 - 901/951 |
<< < 1 2 3 4 5 6 7 8 9 10 |
